Newton

Neurolens is a healthcare technology company founded in 2012, specializing in prescription lenses designed to alleviate symptoms from eye misalignment and digital eye strain. The company’s key innovation is its proprietary Neurolens technology, which features a patented contoured prism that helps align the eyes at various distances. This technology addresses common issues such as headaches, eye strain, and neck pain by reducing the stimulation of the trigeminal nerve caused by visual misalignment. In addition to its lenses, Neurolens offers a Measurement Device that accurately assesses eye misalignment in a quick three-minute scan. This device allows eye care professionals to customize prism correction for each patient, enhancing treatment outcomes. Neurolens primarily serves independent optometrists and eye care providers across North America, helping them provide a new category of lenses that improve patient comfort and visual performance. The company is headquartered in Costa Mesa, California, and has been recognized for its rapid growth in the healthcare sector.

• Employees 150
• Founded 2012
• Annual Revenue $9500000
• Total Funding $209657353